Sign Up | Log In | What is SocialPicks?

Wendy's International Inc (WEN) Trade Now » Rate WEN - Discuss WEN - Add to Watch List

Sector: Services > Industry: Restaurants

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

71.5%

Top:

100.0%

Rate WEN:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

WEN Analysis & Videos »

... View All >

WEN: Bull or Bear?

Cramer on BloggingStocks: China-led drop offers a time to buy WEN

-21.95%
in 100 days

Filed under: Apple Inc (AAPL), Ford Motor (F), Exxon Mobil (XOM), China, Market matters, Citigroup Inc. (C), Target Corp. (TGT), BB and T (BBT), Bristol-Myers Squibb (BMY), Wendy's Intl (WEN), BHP Billiton Ltd ADR (BHP), Freep't McMoRan Copper (FCX), Stocks to Buy, Union Pacific Corporation (UNP), Cramer on BloggingStocks, Potash Corp. of Saskatchewan (POT)

From TheStreet.com Network

TheStreet.com's Jim Cramer says even stocks without exposure to that country will probably be on sale today.

If China has...

Continue reading »

By Jim Cramer (+2.62% risk: moderate) 08/19/09

Comment

McDonald's same-store sales show that the clown still has clout WEN

-84.48%
in 566 days

Filed under: Marketing and advertising, McDonald's (MCD), Yum Brands (YUM), Wendy's Intl (WEN), Burger King Hldgs (BKC), Stocks to Buy

McDonald's (NYSE: MCD) announced its same-store sales results for the month of April Thursday, and the data indicate a healthy fast-food business ("healthy fast food" -- isn't that an oxymoron?).

<>Global comps as a whole increased 5%. Comps for European locations increased 6.3%, and the Asia/Pacific/Middle East/Africa segment saw a 7.8% rise in same-store sales. McDonald's restaurants in the States increased an anemic 2%. The weak domestic sales really need to...

Continue reading »

By Steven Mallas (-36.61% risk: moderate) 05/09/08

Comment

Reinstating Sell Rating on Wendy's, Competition and Distractions Weighing on Company WEN

+83.67%
in 582 days

4/14 - "We have removed the NR designation from Wendy’s shares and add it to the Sell list with a 12-month price target of $21 (10% downside). We expect ongoing operational challenges with market share declines (at the hands of MCD & BKC) which, when coupled with cost burdens, should keep ‘core’ margins pressured. We see a low likelihood of a sale (credit environment/eroding fundamentals), and, with nearly a year of uncertainty under the Special Committee, franchisee discontent is growing and initiatives that could have positively driven sales/margins have been slow to develop (remodels, re...

Continue reading »

By Steven T. Kron (Goldman Sachs) (+83.67% risk: moderate) 04/23/08

Comment

... View All >

People Bullish on WEN

supratrader

Principal

N/A

27 days ago

rhern23

Analyst

N/A

2 mos ago

bighern23

Analyst

N/A

2 mos ago

augustawayne1234

Analyst

N/A

2 mos ago

Jim Cramer

Tracked Blogger

42%

3 mos ago

People Bearish on WEN

william0509

Associate

67%

6 mos ago

gaidengt

Analyst

46%

about 1 year ago

Steven T. Kron (Goldman Sachs)

Tracked Blogger

N/A

about 1 year ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
RIMM	Research in Motion Ltd
NVDA	NVIDIA Corp
V	Visa Inc
FNM	Fannie Mae
MCD	McDonald's Corp.
JPM	JPMorgan Chase & Co

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on WEN

Arby's(R) Launches Giveaway to Celebrate New $5.01 Combos

2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer

Wendy's/Arby's Group, Inc. to Present at Two Investor Conferences in November

Form 8-K WENDY'S/ARBY'S GROUP, For: Nov 05

Wendy's / Arby's Group (WEN) Posts Q3 EPS of $0.03, Beats Estimates

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Wendy's International Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.